Finally, Drug Pricing Consensus: There's No 'Silver Bullet' For This Werewolf
All sides have resorted to the mythological phrase throughout the debate, and industry can only hope that the phase of the moon changes soon.
You may also be interested in...
Ways And Means Drug Pricing Hearing Emphasizes Repetitive, Years-Old Questions
There was little on specific legislative proposals and a lot of time discussing broad questions that Congress has been asking for years about drug pricing.
User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases
House passes bill reauthorizing FDA user fee programs via voice vote and makes many other policy changes, but in the process touts the bill's potential to push drug prices lower.
Trump, Congress And The Search For Common Ground On Drug Pricing
Trump’s ideas for curbing drug pricing have support in Congress but not among those in power; Republican leaders, including the president-elect’s choice for HHS secretary, Tom Price, have long opposed government negotiation in Medicare.